WORK Medical (NASDAQ: WOK) closes $2.1M offshore share sale
Rhea-AI Filing Summary
WORK Medical Technology Group LTD (WOK) reports closing a private placement of new equity. The company issued 2,000,000 Class A ordinary shares at $1.00 per share and 50,000 Class B ordinary shares at $2.50 per share under securities purchase agreements with certain investors. The transaction closed on August 18, 2026 and generated aggregate gross proceeds of approximately $2,125,000, which the company intends to use for business expansion, working capital and general corporate purposes.
The shares were sold in an offshore private placement relying on Section 4(a)(2) and Regulation S exemptions from Securities Act registration, with investors representing they are not U.S. persons and no general solicitation used. After the closing, 4,416,569 Class A and 51,009 Class B ordinary shares were issued and outstanding.
Positive
- None.
Negative
- None.
Filing Explained
The filing adds that the completed private placement report is incorporated by reference into the company’s Form F-3 registration statement; the disclosure still describes the shares as issued under registration exemptions, not as registered or publicly offered shares.
Key Figures
Class A shares issued: 2,000,000 shares
Class B shares issued: 50,000 shares
Subscription price Class A: $1.00 per share
+4 more
7 metrics
Class A shares issued
2,000,000 shares
Class A ordinary shares sold in the private placement at $1.00 per share
Class B shares issued
50,000 shares
Class B ordinary shares sold in the private placement at $2.50 per share
Subscription price Class A
$1.00 per share
Price for Class A ordinary shares in the private placement
Subscription price Class B
$2.50 per share
Price for Class B ordinary shares in the private placement
Gross proceeds
$2,125,000
Aggregate gross proceeds from the private placement
Class A shares outstanding post-transaction
4,416,569 shares
Class A ordinary shares issued and outstanding immediately after closing
Class B shares outstanding post-transaction
51,009 shares
Class B ordinary shares issued and outstanding immediately after closing
Key Terms
Private Placement, Regulation S, Section 4(a)(2), U.S. person, +1 more
5 terms
Private Placement financial
"the Company agreed to issue and sell, in a private placement (the “Private Placement”)"
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.
Regulation S regulatory
"in reliance upon the exemptions ... pursuant to Section 4(a)(2) thereof, and Regulation S promulgated"
Regulation S is a set of rules that allows companies to sell securities (like shares or bonds) to investors outside the United States without having to follow all U.S. securities laws. It matters because it makes it easier for companies to raise money from international investors while still complying with U.S. regulations.
Section 4(a)(2) regulatory
"in reliance upon the exemptions from the registration requirements ... pursuant to Section 4(a)(2)"
Section 4(a)(2) is a part of U.S. securities laws that allows companies to sell their stock directly to certain investors without registering the sale with regulators. This process is often used for private placements, making it easier and faster for companies to raise money from knowledgeable or institutional investors. It matters to investors because it provides an alternative way to buy shares, often with fewer disclosures and lower costs.
U.S. person regulatory
"Each Investor represented that it is not a “U.S. person” in accordance with Regulation S"
A U.S. person is anyone or any entity treated as subject to U.S. rules for taxes, securities and other regulations — typically U.S. citizens, lawful permanent residents, people who live in the U.S. long-term, and companies, trusts or estates organized under U.S. law. It matters to investors because being classified as a U.S. person can determine what investments you may buy, what disclosures or reports are required, and which tax and compliance obligations apply, like a membership badge that decides which rulebook governs you.
incorporated by reference regulatory
"This report shall be deemed to be incorporated by reference into the registration statement"
FAQ
What capital did WORK Medical Technology Group LTD (WOK) raise in the August 2026 private placement?
WORK Medical Technology Group LTD raised approximately $2,125,000 in gross proceeds by issuing 2,000,000 Class A shares at $1.00 and 50,000 Class B shares at $2.50 in a private placement that closed on August 18, 2026.
How will WOK use the proceeds from the August 2026 private placement?
The company plans to use the approximately $2,125,000 in gross proceeds for business expansion, working capital and general corporate purposes, according to its disclosure.
Under which exemptions did WOK conduct the August 2026 private placement?
The offering relied on exemptions from Securities Act registration under Section 4(a)(2) and Regulation S. Investors represented they are not U.S. persons, and the company stated it did not use general solicitation or public offering methods.
Is the August 2026 private placement information incorporated into WOK’s Form F-3 shelf registration?
Yes. The report states it is deemed incorporated by reference into WORK Medical Technology Group LTD’s Form F-3 registration statement (File No. 333-289943) and is part of that registration from the filing date, unless later superseded.
AI-generated analysis. How Rhea-AI works. Not financial advice.
